StockData
BioNexus Gene Lab Corp logo

BioNexus Gene Lab Corp (BGLC) stock

BGLCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3090% below fair value
$0.77−0.05 (-6.56%)

Close on Nov 17, 2026Market cap $2.25MP/E –Yield –

BioNexus Gene Lab enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

BioNexus Gene Lab's enterprise value was $843.57K on Nov 11, 2026, against $7.00M a year earlier. Over the last 5 years it ranged from $843.57K to $43.76B, with a median of $81.73M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$843.57K-85.8%
2025Dec 31, 2025$5.94M-87.1%
2024Dec 31, 2024$46.12M-47.7%
2023Dec 29, 2023$88.15M-99.6%
2022Dec 30, 2022$19.80B-54.7%
2021Dec 31, 2021$43.76B+54.4%
2020Dec 31, 2020$28.35B–

More BioNexus Gene Lab figures

See a number that looks wrong?